Insider Transactions in Q2 2023 at Abeona Therapeutics Inc. (ABEO)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 20
2023
|
Michael Amoroso Director |
SELL
Open market or private sale
|
Direct |
338
-0.29%
|
$1,352
$4.45 P/Share
|
|
Jun 14
2023
|
Leila Alland Director |
BUY
Grant, award, or other acquisition
|
Direct |
58,689
+42.59%
|
$234,756
$4.62 P/Share
|
|
Jun 14
2023
|
Donald A. Wuchterl Director |
BUY
Grant, award, or other acquisition
|
Direct |
58,689
+42.59%
|
$234,756
$4.62 P/Share
|
|
Jun 14
2023
|
Christine Berni Silverstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
58,689
+38.38%
|
$234,756
$4.62 P/Share
|
|
Jun 14
2023
|
Faith L. Charles Director |
BUY
Grant, award, or other acquisition
|
Direct |
58,689
+42.59%
|
$234,756
$4.62 P/Share
|
|
Jun 14
2023
|
Michael Amoroso Director |
BUY
Grant, award, or other acquisition
|
Direct |
58,689
+33.76%
|
$234,756
$4.62 P/Share
|
|
Jun 14
2023
|
Mark Alvino Director |
BUY
Grant, award, or other acquisition
|
Direct |
58,689
+43.5%
|
$234,756
$4.62 P/Share
|
|
Jun 05
2023
|
Brendan M. O'Malley SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
90,902
+33.02%
|
-
|
|
Jun 05
2023
|
Joseph Walter Vazzano Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
141,908
+37.51%
|
-
|
|
Jun 05
2023
|
Vishwas Seshadri Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
336,826
+40.17%
|
-
|
|
Jun 02
2023
|
Vishwas Seshadri Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
827
-0.5%
|
$2,481
$3.06 P/Share
|
|
Apr 25
2023
|
Mark Alvino Director |
SELL
Open market or private sale
|
Direct |
887
-4.82%
|
$2,661
$3.25 P/Share
|
|
Apr 03
2023
|
Brendan M. O'Malley SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
104
-0.11%
|
$208
$2.82 P/Share
|